Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis - Top-Institutions - MDSpire

Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis

  • By

  • Maria Neu

  • Ehab Shiban

  • Philipp Krauss

  • Björn Sommer

  • Zoha Roushan

  • Susanne Gutser

  • Christoph J. Maurer

  • Tilman Janzen

  • Georg Stüben

  • Klaus-Henning Kahl

  • August 13, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #5

    University of Heidelberg Medical Center
    University of Heidelberg Medical Center

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

Original Source(s)

Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis

  • by Maria Neu, Ehab Shiban, Philipp Krauss, Björn Sommer, Zoha Roushan, Susanne Gutser, Christoph J. Maurer, Tilman Janzen, Georg Stüben, Klaus-Henning Kahl

  • August 13, 2025

Related Content

Bidirectional roles of meningeal lymphatic vessels in brain metastases: friend and foe

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies